Osmotica Pharmaceuticals plc Business Finance Contracts & Agreements

21 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
DIP Facility Agreement, dated as of October 16, 2023, by and between the Debtors, Athyrium Opportunities IV Acquisition LP, as administrative agent and collateral agent, and...
Facility Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2023
Form of Securities Purchase Agreement, dated August 15, 2023
Purchase Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2023
Form of Placement Agent Ordinary Warrant
Warrant Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
2023
Form of Series A-2 Ordinary Warrant
Warrant Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
2023
Form of Series A-1 Ordinary Warrant
Warrant Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
2023
Form of Pre-Funded Warrant
Warrant Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
2023
Third Amendment to Note Purchase Agreement, dated August 13, 2023, by and among RevitaLid Pharmaceutical Corp., the Guarantors party thereto, the Purchasers party thereto and...
Note Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
2023
Second Amendment to Note Purchase Agreement, dated March 8, 2023, by and among RevitaLid
Note Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
2023
RVL Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan
Share Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2022
Form of Warrant
Warrant Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2021
Underwriting Agreement, dated October 6, 2021, by and between Osmotica Pharmaceuticals plc and H.C. Wainwright & Co., LLC
Underwriting Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2021
Share Subscription Agreement dated October 1, 2021, between Osmotica Pharmaceuticals plc and Athyrium Opportunities IV Acquisition LP
Share Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2021
Note Purchase Agreement dated October 1, 2021, between Osmotica Pharmaceutical Corp., Osmotica Pharmaceuticals plc, Osmotica Holdings US LLC, Athyrium Opportunities IV Acquisition...
Note Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2021
Purchase and Sale Agreement, dated as of June 24, 2021, by and among Osmotica Pharmaceuticals plc, Acella Holdings, LLC, Alora Pharmaceuticals, LLC and the Sellers listed therein
Purchase Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2021
Osmotica Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan
Share Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2020
Underwriting Agreement, dated July 13, 2019, by and between Osmotica Pharmaceuticals plc and Credit Suisse Securities (USA) LLC
Underwriting Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2020
Form of Underwriting Agreement
Underwriting Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
NY
2020
Osmotica Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan
Share Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2019
Shareholders' Agreement
Shareholders Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2019
OSMOTICA PHARMACEUTICALS PLC 2018 EMPLOYEE SHARE PURCHASE PLAN
Share Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2018
Form of Shareholders' Agreement
Shareholders Agreements
Osmotica Pharmaceuticals plc
Pharmaceuticals
DE
2018